2022
DOI: 10.1007/s12026-022-09279-8
|View full text |Cite
|
Sign up to set email alerts
|

ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 55 publications
0
3
0
Order By: Relevance
“…On the contrary, treatment of IgG4-RD should be started with glucocorticoids, without immunosuppressive treatment in the first line [ 2 , 41 ]. Recent reports suggest that rituximab, anty-CD20 therapy or cyclophosphamide could be used in ANCA-associated vasculitis/IgG4-RD overlap syndrome [ 26 , 42 , 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the contrary, treatment of IgG4-RD should be started with glucocorticoids, without immunosuppressive treatment in the first line [ 2 , 41 ]. Recent reports suggest that rituximab, anty-CD20 therapy or cyclophosphamide could be used in ANCA-associated vasculitis/IgG4-RD overlap syndrome [ 26 , 42 , 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Ocular manifestations in the course of the disease were seen in ca 26–50% of patients with GPA [ 15 , 16 , 17 ]. In 15.6–19.3% of cases, ocular symptoms constituted the first sign of the disease [ 15 , 18 , 19 , 20 , 21 ]. Thus, an ophthalmologist should consider the diagnosis of GPA, especially in cases where other features of the disease, such as pulmonary or renal disease, are absent.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, overdiagnosis has become a more prominent problem in recent years because IgG4‐RD is one of the greatest mimickers by other diseases, rendering accurate diagnosis profoundly challenging. These include but are not limited to, tumors (eg, lymphoma, solid tumors, and inflammatory myofibroblastic tumor 5 ), connective tissue diseases (eg, anti‐neutrophilic cytoplasmic antibody [ANCA]‐associated vasculitis 6 and Sjögren's syndrome 7 ), hematological diseases (eg, Castleman's disease, 8 Rosai‐Dorfman disease, 9 and Kimura's disease 10 ), sarcoidosis, Erdheim‐Chester disease 11 and chronic infections (eg, chronic fungal infection 12 ).…”
Section: Figurementioning
confidence: 99%